PATENT CLAIM ANALYSIS

Application Number: 15745714
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["549", "022000"]

Abstract:
The invention relates to Pro-drugs, comprising red-ox-sensitive cleavage sites. The compounds may be utilized in medical practice for targeting of si RNA, antisense oligonucleotides or protein-based therapeutics to the cytoplasmatic compartment of cells both in vitro or in vivo, in a subject in need.

Claim (Index 7):
A Pro-drug according to  claim 2 , comprising the structure as set forth in Formula (V), or its related reduced analogue with free thiol groups: including pharmaceutically acceptable salts, hydrates, solvates and metal chelates of the compound represented by the structure as set forth in Formula (V), and solvates and hydrates of the salts, wherein L 1 , L 4  and * are as defined in  claim 1 .

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.28947
- Patent Class: 549.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15691821', '15222559', '14872179', '14830799', '10585928']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7321172238342825
- 35 USC 102 Novelty (BERT): 0.5122641268879912
- Combined Prediction Score: 0.7101319141396534
- Mean Citation Score: 271.216316
- Max Citation Score: 300.4459
- Similarity Product: 224.26213150385607

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test